[27-52-pm1] Science for Drug Formulation 3, Testing, property and stability of medicinal formulation, Novel formulations/Others | The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

Advanced Search

Session Details

Poster Presentation(E) Pharmaceutical Health Care and Sciences

[27-52-pm1]Science for Drug Formulation 3, Testing, property and stability of medicinal formulation, Novel formulations/Others

Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC

Room 52 (B305, Bldg. 1, Area 2 [3F])

Discusser: Muneaki Hidaka, Yuki Takahashi

[27-52-pm1-01]Dissolution behavior of Kakkonto extract formulations using the flow-through cell method

○Yu Mano^1,2, Riku Azuma¹, Yugo Uematsu¹, Hiroko Otake¹, Fumihiko Ogata¹, Naohito Kawasaki¹, Noriaki Nagai¹ (1. Pharm., Kindai Univ.,, 2. Pharm., Bell Land General Hospital)

[27-52-pm1-02]Feasibility Evaluation of the Simple Suspension Method for Orexin Receptor Antagonists

○Koyo Oishi¹ (1. Grad.Sch.Pharm.Sci.,Aichigakuin Univ)

[27-52-pm1-03]Effect of Proteolytic Enzymes and Digestion Conditions on Deamidation Assessment of Antibody Therapeutics

○Haruhiko Kamada^1,2,3, Yuko Yamanada¹ (1. National Institutes of Biomedical Innovation, Nutrient and Health, 2. Grad. Sch. Facult. Pharm. Sci., Kyoto Univ., 3. Grad. Sch. Pharm. Sci., Univ. Osaka)

[27-52-pm1-04]Issues in dissolution testing of Kampo medicines: Evaluation of Saikokaryukotsuboreito Extract Granules

○Naoki Yamada¹, Masaki Takao¹, Shogo Ito¹, Minori Iida¹, Rio Ikeda¹, Masayuki Ishimaru¹, Takahiro Toyoshima¹, Yukinori Katori¹ (1. TSUMURA & CO.)

[27-52-pm1-05]Micronization of Mefenamic Acid for Improved Dispersion Stability

Miyu Sakaguchi¹, Kaoru Hirose¹, Yuko Wada², Fumiyoshi Ishii², Kaoru Oda³, ○Takehisa Hanawa¹ (1. Tokyo Univ. of Science, 2. Meiji Pharm. Univ., 3. Summit Pharmaceuticals International Co., Ltd.)

[27-52-pm1-06]Delopment of Levofloxacin Hemihydrate Loaded In Situ Forming Gel for Peri-Implantitis Treatment

○Napaphol Puyathorn¹, Thawatchai Phaechamud², Pimlada Sinpanee³, Nutcha Katongtung³ (1. Department of Pharmaceutical Sciences, Faculty of pharmacy, Chiang Mai University, 2. Department of Pharmaceutical Sciences, Faculty of pharmacy, Silpakorn University, 3. Faculty of pharmacy, Chiang Mai University)

[27-52-pm1-07]Moisture absorption behavior of Benzalkonium Chloride (BAC) and its control strategy

○Hiroki Muro¹, Hisaki Kojima¹ (1. Rohto Nitten Co., Ltd.)

[27-52-pm1-08]Practical points to note and improvement proposals for conducting Japanese Pharmacopoeia tests
~ Recommendations for quality improvement through GMP verification ~

○Hisaki Kojima¹, Hiroki Muro¹ (1. Rohto Nitten Co., Ltd.)

[27-52-pm1-09]Evaluation of pharmaceutical properties between brand and generic products (22): Silicone or Strat-M membrane permeation rate of original and generic tapes containing Tulobuterol

○Ken-ichi Shimokawa¹, Natsuki Ichimura¹, Maiko Kawashima¹, Takehisa Hanawa², Yuko Wada¹, Fumiyoshi Ishii¹ (1. Meiji Pharm. Univ., 2. Tokyo Univ. of Sci.)

[27-52-pm1-10]Machine Learning Model for Optimizing Forming Conditions of Biomass Blister Packaging

○Junya Zogo¹, Susumu Hasegawa¹ (1. Daiichi Sankyo Co., Ltd.)

Back to Category List